COVID-19 Synthetic Minigene Vaccine Trial
Part of Infections clinical trials.
This trial tests a new type of COVID-19 vaccine called a synthetic minigene vaccine. It is for people with a recent COVID-19 infection (within the past 7 days) to see if the vaccine is safe and helps the immune system fight the virus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive lab test (PCR) for COVID-19 from a throat swab, sputum, or lower airway sample.
- Your symptoms started no more than 7 days ago (fever is the main sign, but if no fever, cough or other symptoms count).
- Your white blood cell count must be at least 3,500 per microliter, and your lymphocytes (a type of immune cell) at least 750 per microliter.
- You must test negative for HIV, hepatitis B, hepatitis C, and tuberculosis.
- You cannot be allergic to albumin (a protein used in some medicines).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
This trial tests a new COVID-19 vaccine designed to teach your immune system (T-cells) to fight the coronavirus. It is mainly for healthy adults who are not recently infected or vaccinated, to see how safe it is and how your immune system responds.
This study compares how well the mRNA Covid-19 vaccine works when given through different methods (like a needle or a jet injector). It may help find a more comfortable or effective way to get vaccinated.
This trial studies how viruses affect the body, and how the immune system responds, in both healthy people and people with weakened immunity. It may include people who currently have a suspected or recent viral infection, close contacts, people around the time of a viral vaccine, and healthy adults used for comparison.
Hear when a new Pathogen Infection Covid-19 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.